Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 286337011000036110 | epoetin beta 4000 international units / 0.3 mL injection, 0.3 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 286339011000036115 | epoetin beta 4000 units/0.3 mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| epoetin beta 4000 units/0.3 mL injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| epoetin beta 4000 units/0.3 mL injection, syringe | Is a | epoetin beta | true | Inferred relationship | Some | ||
| epoetin beta 4000 units/0.3 mL injection, syringe | has intended active ingredient | epoetin beta | true | Inferred relationship | Some | 842221290 | |
| epoetin beta 4000 units/0.3 mL injection, syringe | has Australian BoSS | epoetin beta | true | Inferred relationship | Some | 842221290 | |
| epoetin beta 4000 units/0.3 mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| epoetin beta 4000 units/0.3 mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 842221291 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Neorecormon 4000 units/0.3 mL injection, 0.3 mL syringe | Is a | True | epoetin beta 4000 units/0.3 mL injection, syringe | Inferred relationship | Some | |
| epoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes | has MPUU | True | epoetin beta 4000 units/0.3 mL injection, syringe | Inferred relationship | Some | 1 |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product unit of use reference set
FHIR